Save Product
Product Details
Product Overview
Human G-CSF ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human G-CSF that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ELISA Kit provides several benefits:
- Standards to calibrate with NIBSC/WHO standards for comparable results.
- Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
- High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
- Simplified and straightforward protocols and ready-to-use reagents to save assay time.
Product Specifications
Assay TypeSandwich-ELISAAnalyteG-CSFFormat96-wells plate breakable into 12 x 8 wells stripsReactivityHumanSensitivity< 6.25 pg/mLAssay Time2 hr 20 minSample volume50 μLRange6.25 pg/mL-400 pg/mLSample TypeFor the quantitative determination of human G-CSF in serum, plasma and cell supernatant.Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.
Application
The kit is developed for quantitative detection of natural and recombinant human G-CSF in serum, plasma and cell culture supernatants.
It is for research use only.
Workflow
Storage
Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Materials Provided
IDComponentsSizeCEA221-C01Pre-coated Anti-G-CSF Antibody Microplate1 plateCEA221-C02Human G-CSF Standard15 μgCEA221-C03Biotin-Anti-G-CSF Antibody20 μgCEA221-C04Streptavidin-HRP50 μLCEA221-C0510×Washing Buffer50 mLCEA221-C062×Dilution Buffer50 mLCEA221-C07Substrate Solution12 mLCEA221-C08Stop Solution7 mLACRO Quality Management System
Customers Also Viewed
Performance Data
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was cal-culated based on the results of the standard curve. The minimum detectable concentration of G-CSF is less than 6.25 pg/mL.
Sample Values
Serum Sample: Thirty healthy donor serum samples were evaluated for the concentrations of human G-CSF in assay.
Cell Culture Supernatant: PBMC (5.0 × 10⁶ cells/mL) were cultured in 1640 supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 ug/mL streptomycin sulfate. Cells were cultured unstimulated or stimulated with 0.1 ug/mL LPS for 2 days or 5 days. Subsequent analysis involved quantitative measurement of human G-CSF concentrations in collected culture supernatants using standardized immunoassays.
Intra-Assay Statistics
Ten replicates of each of three samples containing different G-CSF concentrations were tested in one assay. Acceptable criteria: CV＜10%.
Inter-Assay Statistics
Three samples containing different concentrations of G-CSF were tested in inde-pendent assays. Acceptable criteria: CV<15%.
Recovery
Recombinant G-CSF was spiked into three human serum samples, and then ana-lyzed. The average recovery of G-CSF for serum samples is 101.2%.
Customer Reviews Writing Reviews
Recent Advances
Drug Development Progress- English Name：
Granulocyte colony-stimulating factor
- Category：
- Approved Drugs：
0 Details
- Drugs in Clinical Trials：
3 Details
- Highest Development Stage：
Phase 2 Clinical
Contact Us
Drug Candidate Licensing
